Pathology of skeletal muscle cells in adult-onset glycogenosis type II (Pompe disease): Ultrastructural study

Folia Neuropathologica

Volumn 46, Issue 2, 2008, Pages 123-133

  Lewandowska, Eliza ^a   Wierzba Bobrowicz, Teresa ^a   Rola, Rafał ^a   Modzelewska, Joanna ^a   Stepień, Tomasz ^a   Ługowska, Agnieszka ^a   Pasennik, Elzbieta ^a   Ryglewicz, Danuta ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Adult onset Pompe disease; Autophagic vacuoles; Lysosomes; Skeletal muscle cells; Ultrastructure

Indexed keywords

GLYCOGEN;

ADULT; ARTICLE; CASE REPORT; CELL ULTRASTRUCTURE; CELL VACUOLE; CYTOPLASM; DISEASE COURSE; DYSPNEA; ELECTRON MICROSCOPY; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; HUMAN CELL; HUMAN TISSUE; LYSOSOME; MITOCHONDRION; MUSCLE BIOPSY; MUSCLE CELL; ONSET AGE; SKELETAL MUSCLE; SYMPTOM;

EID: 48049091588     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cardiff RD. A histochemical and electron microscopic study of skeletal muscle in a case of Pompe's disease (glycogenosis II). Pediatrics 1966; 37: 249-259.
2. Fidziańska A, Walczak E, Walski M. Abnormal chaperone-mediated autophagy (CMA) in cardiomyocytes of a boy with Danon disease. Folia Neuropathol 2007; 45: 133-139.
3. Fukuda T, Ahearn M, Roberts A, Mattaliano RJ, Zaal K, Ralston E, Plotz PH, Raben N. Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe Disease. Mol Ther 2006; 14: 831-839.
4. Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, Plotz PH, Raben N. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 2006; 59: 700-708.
5. Geel TM, McLaughlin PM, de Leij LF, Ruiters MH, Niezen-Koning KE. Pompe disease: current state of treatment modalities and animal models. Mol Genet Metab 2007; 92: 299-307.
6. Griffin JL. Infantile acid maltase deficiency. I. Muscle fiber destruction after lysosomal rupture. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 45: 23-36.
7. Hagemans ML, Winkel LP, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, Van der Ploeg AT. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005; 128: 671-677.
8. Hesselink RP, Wagenmakers AJ, Drost MR, Van der Vusse GJ. Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II. Biochem Biophys Acta 2003; 1637: 164-170.
9. Kiffin R, Bandyopadhyay U, Cuervo AM. Oxidative stress and autophagy. Antioxid Redox Signal 2006; 8: 152-162.
10. Raben N, Fukuda T, Gilbert AL, de Jong D, Thurberg BL, Mattaliano RJ, Meikle P, Hopwood JJ, Nagashima K, Nagaraju K, Plotz PH. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol Ther 2005; 11: 48-56.
11. Raben N, Plotz P, Byrne BJ. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2002; 2: 145-166.
12. Selak MA, de Chadarevian JP, Melvin JJ, Grover WD, Salganicoff L, Kaye EM. Mitochondrial activity in Pompe's disease. Pediatr Neurol 2000; 23: 54-57.
13. Sharma MC, Schultze C, von Moers A, Stoltenburg-Didinger G, Shin YS, Podskarbi T, Isenhardt K, Tews DS, Goebel HH. Delayed or late-onset type II glycogenosis with globular inclusion. Acta Neuropathol 2005; 110: 151-157.
14. Tanaka K, Shimazu S, Oya N, Tomisawa M, Kusunoki T, Soyama K, Ono E. Muscular form of glycogenosis type II. Pediatrics 1979; 63: 124-129.
15. Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC, Bossen EH, Kishnani PS, O'Callaghan M. Characterization of pre-and post-treatment pathology after enzyme replacement therapy for pompe disease. Lab Invest 2006; 86: 1208-1220.
16. Wie'zba-Bobrowicz T, Lewandowska E, Lugowska A, Rola R, Stepień T, Ryglewicz D, Pasennik E. Adult glycogenosis type II (Pompe's disease): morphological abnormalities in muscle and skin biopsies compared with acid alpha-glucosidase activity. Folia Neuropathol 2007; 45: 179-186.